Antibiotic Profile of Pathogenic Bacteria Isolated in Pub... | NCT05106803

Studies
Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan

NCT05106803

Sponsor

Yarmouk University

Status

Completed

Last Update Posted

Nov 4, 2021Actual

Enrollment

24Actual

Phase

Not provided

Conditions

Bacterial Infections
Antibiotic Resistant Infection
Surgical Site Infection

Interventions

ciprofloxacin

Countries

Jordan

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Oct 2021

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 1, 2019Actual

Primary Completion Date

Oct 1, 2019Actual

Completion Date

Oct 1, 2019Actual

First Submitted Date

Oct 24, 2021

First Submission Date that Met QC Criteria

Oct 24, 2021

First Posted Date

Nov 4, 2021Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Oct 24, 2021

Last Update Posted Date

Nov 4, 2021Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Yes

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.

Detailed Description

Background: Surgical site infections are hospital-acquired, vary from one hospital to another, and can cause significant postoperative morbidity, mortality, and prolonged hospital stay.

Aim: The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.

Methods: Postsurgical wound samples were collected and processed in a microbiology laboratory using standard microbiological techniques. Antibiotic susceptibility tests were performed using 13 antibiotics covering the gram-positive and gram-negative bacteria using the disc diffusion test.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

24Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Wound infection		Patients with surgical site infection as diagnosed by the attending physician	Drug: ciprofloxacin

Interventions

Name	Type	Description	Arm Group Labels	Other Names
ciprofloxacin	Drug	Antibiotics used in vitro n the study	Wound infection

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Positive culture	Positive swab culture from the wound	August 2019 to October 2019

Secondary Outcomes

Measure	Description	Time Frame
Gram stain and type of Bacteria	Gram stain and type of Bacteria grown in culture media	August 2019 to October 2019
Antibiotic Susceptibility	Antibiotic Susceptibility to the isolated organisms

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Post-Surgical Wound Infection

Exclusion Criteria:

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

A hospital-based prospective study was carried out in Public-Teaching Hospital in northern Jordan with a total capacity of 400 beds, All patients meet the criteria of getting post-operative wound infections in different surgical wards and ICUs.

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Raed M Ennab	Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Yarmouk University		Irbid		21163	Jordan

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D001424	Bacterial Infections
D013530	Surgical Wound Infection

Ancestor Terms

ID	Term
D001423	Bacterial Infections and Mycoses
D007239	Infections
D014946	Wound Infection
D011183	Postoperative Complications

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D002939	Ciprofloxacin
D015662	Trimethoprim, Sulfamethoxazole Drug Combination
D009643	Norfloxacin
D004917	Erythromycin
D002701	Chloramphenicol
D005839	Gentamicins
D013752	Tetracycline
D014640	Vancomycin
D019980	Amoxicillin-Potassium Clavulanate Combination
D000077723	Cefepime
D010406	Penicillins
D000667	Ampicillin
D002981	Clindamycin
D010068	Oxacillin

Ancestor Terms

ID	Term
D024841	Fluoroquinolones
D042462	4-Quinolones
D015363	Quinolones
D011804	Quinolines

Browse Leaves

Not provided

Browse Branches

Not provided